Cargando…

Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes

BACKGROUND: The current study was to evaluate the effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes. METHODS: This is an open-label, parallel and controlled study. Participants were divided into canagliflozin (100 ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Zirui, Sun, Yue, Li, Guiping, Shen, Yuli, Wen, Yingzhen, Liu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830023/ https://www.ncbi.nlm.nih.gov/pubmed/35144596 http://dx.doi.org/10.1186/s12902-022-00949-0

Ejemplares similares

Effects of Dapagliflozin and Sitagliptin on Insulin Resistant and Body Fat Distribution in Newly Diagnosed Type 2 Diabetic Patients
por: Sun, Yue, et al.
Publicado: (2020)

Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
por: Du, Xuan, et al.
Publicado: (2018)

Can visceral adipose tissue and skeletal muscle predict recurrence of newly diagnosed Crohn’s disease in different treatments
por: Zhang, Zinan, et al.
Publicado: (2022)

Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
por: Tan, Bee K., et al.
Publicado: (2009)

SUBCUTANEOUS ADIPOSE TISSUE INSULIN RESISTANCE IS ASSOCIATED WITH VISCERAL ADIPOSITY IN POSTMENOPAUSAL WOMEN
por: Casey, Beret A., et al.
Publicado: (2014)

Negative association of acetate with visceral adipose tissue and insulin levels
por: Layden, Brian T, et al.
Publicado: (2012)

Visceral Adipose Tissue is Associated with Insulin Resistance in Hemodialyzed Patients
por: Giers, Kinga, et al.
Publicado: (2015)

Visceral Adipose Tissue Phospholipid Signature of Insulin Sensitivity and Obesity
por: Palau-Rodriguez, Magalí, et al.
Publicado: (2021)

Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016)

Subcutaneous adipose tissue & visceral adipose tissue
por: Mittal, Balraj
Publicado: (2019)

Rapid Changes in Serum Testosterone in Men With Newly Diagnosed Type 2 Diabetes With Intensive Insulin and Metformin
por: Hu, Yun, et al.
Publicado: (2021)

Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue
por: Bensussen, Antonio, et al.
Publicado: (2023)

Efficacy and tolerability of sitagliptin and metformin compared with insulin as an initial therapy for newly diagnosed diabetic patients with severe hyperglycaemia
por: He, Mingqian, et al.
Publicado: (2021)

Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes
por: Seghieri, Marta, et al.
Publicado: (2018)

Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes
por: Shi, Chunhong, et al.
Publicado: (2019)

Epicardial Adipose Tissue Increased in Patients with Newly Diagnosed Subclinical Hypothyroidism
por: Korkmaz, Levent, et al.
Publicado: (2012)

Visceral adiposity, insulin resistance and cancer risk
por: Donohoe, Claire L, et al.
Publicado: (2011)

Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects
por: Cheon, Dae Young, et al.
Publicado: (2017)

The Predictive Value of Visceral Adiposity Index and Lipid Accumulation Index for Microalbuminuria in Newly Diagnosed Type 2 Diabetes Patients
por: Qi, Licui, et al.
Publicado: (2021)

Metformin Prevents Key Mechanisms of Obesity-Related Complications in Visceral White Adipose Tissue of Obese Pregnant Mice
por: Schmitz, Katrin, et al.
Publicado: (2022)

Effects and Mechanisms of Dapagliflozin Treatment on Ambulatory Blood Pressure in Diabetic Patients with Hypertension
por: Hao, Zirui, et al.
Publicado: (2020)

Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
por: Amato, Marco Calogero, et al.
Publicado: (2014)

Depletion of Regulatory T Cells in Visceral Adipose Tissues Contributes to Insulin Resistance in Hashimoto's Thyroiditis
por: Yang, Min, et al.
Publicado: (2018)

Netrin-1 Promotes Visceral Adipose Tissue Inflammation in Obesity and Is Associated with Insulin Resistance
por: Mentxaka, Amaia, et al.
Publicado: (2022)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue
por: Gonzalez-Franquesa, Alba, et al.
Publicado: (2022)

Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
por: Fleming, Joshua W, et al.
Publicado: (2015)

Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview
por: Davidson, Jaime A., et al.
Publicado: (2016)

Comparative Liquid Chromatographic Study for Concurrent Determination of Canagliflozin and Metformin in Combined Tablets
por: Zaghary, Wafaa A., et al.
Publicado: (2017)

Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect
por: Corremans, Raphaëlle, et al.
Publicado: (2023)

Comment on ‘Epicardial Adipose Tissue Increased in Patients with Newly Diagnosed Subclinical Hypothyroidism’
por: Atalay, Murat
Publicado: (2013)

T Regulatory Cells in the Visceral Adipose Tissues
por: Fooks, Allen N., et al.
Publicado: (2021)

PCSK9 is Expressed in Human Visceral Adipose Tissue and Regulated by Insulin and Cardiac Natriuretic Peptides
por: Bordicchia, Marica, et al.
Publicado: (2019)

Visceral adipose tissue but not subcutaneous adipose tissue is associated with urine and serum metabolites
por: Schlecht, Inga, et al.
Publicado: (2017)

Regulatory T cells differentiation in visceral adipose tissues contributes to insulin resistance by regulating JAZF‐1/PPAR‐γ pathway
por: Meng, Fanping, et al.
Publicado: (2023)

Non-linear Associations Between Visceral Adipose Tissue Distribution and Anthropometry-Based Estimates of Visceral Adiposity
por: Scafoglieri, Aldo, et al.
Publicado: (2022)

Echocardiographic Assessment of Epicardial Adipose Tissue - A Marker of Visceral Adiposity
por: Singh, Navneet, et al.
Publicado: (2007)

IGFBP-3 Interacts with the Vitamin D Receptor in Insulin Signaling Associated with Obesity in Visceral Adipose Tissue
por: Moreno-Santos, Inmaculada, et al.
Publicado: (2017)

Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes
por: Qiu, Rong, et al.
Publicado: (2016)

Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China
por: Hou, Xingyun, et al.
Publicado: (2019)

Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation
por: Lieb, David C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ssqg6hgjh83v59am3jcuas03kv